-
Mashup Score: 1Oral Arsenic Regimen for APL Deemed “Revolutionary” - 5 month(s) ago
For patients with acute promyelocytic leukemia, swapping out IV therapy could transform patients’ lives without compromising survival.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Artificial Intelligence Identifies Novel Disease Pathways - 5 month(s) ago
Software pinpoints signs of breast cancer that genomic testing can miss.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Optimism Surrounds Claudin 18.2 ADC - 5 month(s) ago
CMG901 improves survival in gastric/GEJ cancers in Asian trial, but more study needed, researchers say.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2ARPA-H Funds Two “Manhattan Projects” for Cancer - 6 month(s) ago
Efforts tackle big goals for the oncology community.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Personalized DNA Vaccine Immunogenic Against Melanoma - 6 month(s) ago
EVX-02 elicits robust and lasting T-cell responses.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5Tarlatamab Shows Promise in SCLC - 6 month(s) ago
A novel drug targeting DLL3 could be a therapeutic option in late-line disease.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Expanding “Practice-Changing” Belzutifan's Reach in RCC - 6 month(s) ago
HIF-2α inhibitor’s efficacy, tolerability boost enthusiasm for use beyond VHL disease–associated cancers.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0AMG 193 Effective in Multiple Tumor Types - 6 month(s) ago
Second-generation PRMT5 inhibitor less toxic than predecessors.
Source: aacrjournals.orgCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 0Nobel-Honored mRNA Tech Advancing Cancer Therapy - 6 month(s) ago
Chemical tweaks found in COVID-19 vaccines are enabling innovations in oncology.
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0Modifying Trial Design May Be Key to Full Sotorasib Approval - 6 month(s) ago
Current PFS data from CodeBreaK 200 not interpretable, ODAC says.
Source: aacrjournals.orgCategories: Hem/Onc News and Journals, Latest HeadlinesTweet
#NewsInBrief— Oral Arsenic Regimen for APL Deemed “Revolutionary." https://t.co/GxGcopKhKs https://t.co/qSrqutKOu7